Viewing Study NCT03155503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2026-03-11 @ 6:42 AM
Study NCT ID: NCT03155503
Status: COMPLETED
Last Update Posted: 2018-05-29
First Post: 2017-05-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
Sponsor: Suven Life Sciences Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Depressive Disorder, Major View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SUVN-911 View
None Depression View
None single dose View
None multiple dose View
None alpha4 beta2 receptor View
None first in human View
None safety View
None pharmacokinetics View
None tolerability View